Планирование и ведение беременности у пациенток с синдромом множественных эндокринных неоплазий 1 типа

1. Thakker R.V. Genetics of parathyroid tumours. J Intern Med. 2016; 280(6): 574–83. DOI: 10.1111/joim.12523
2. Giusti F., Cianferotti L., Boaretto F., Cetani F., Cioppi F., Colao A., et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017; 58(2): 349–59. DOI: 10.1007/s12020-017-1234-4
3. Sakurai A., Suzuki S., Kosugi S., Okamoto T., Uchino S., Miya A. etal. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol (Oxf). 2012; 76(4): 533–9. DOI: 10.1111/j.1365-2265.2011.04227.x
4. Trouillas J., Labat-Moleur F., Sturm N., Kujas M., Heymann M.-F., Figarella-Branger D., et al. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol. 2008; 32(4): 534–43. DOI: 10.1097/PAS.0b013e31815ade45
5. Goudet P., Murat A., Binquet C., Cardot-Bauters C., Costa A., Ruszniewski P., et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010; 34(2): 249–55. DOI: 10.1007/s00268-009-0290-1
6. Ito T., Igarashi H., Uehara H., Berna M.J., Jensen R.T. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore). 2013; 92(3):135–81. DOI: 10.1097/MD.0b013e3182954af1
7. Schaaf L., Pickel J., Zinner K., Hering U., Hofler M, Goretzki P.E., et al. Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. 2007; 115(8): 509–17. DOI: 10.1055/s-2007-970160
8. Manoharan J., Raue F., Lopez C.L., Albers M.B., Bollmann C., Fendrich V., et al. Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary? World J Surg. 2017; 41(8): 2026–32. DOI: 10.1007/s00268-017-3992-9
9. Machens A., Schaaf L., Karges W., Frank-Raue K., Bartsch D.K., Rothmund M., et al. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clin Endocrinol (Oxf). 2007; 67(4): 613–22. DOI: 10.1111/j.1365-2265.2007.02934.x
10. Triponez F., Sadowski S.M., Pattou F., Cardot-Bauters C., Mirallie E., Le Bras M., et al. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small </=2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d’Etude des Tumeurs Endocrines. Ann Surg. 2018; 268(1):158–64. DOI: 10.1097/SLA.0000000000002191
11. de Laat J.M., Pieterman C.R.C., Weijmans M., Hermus A.R., Dekkers O.M., de Herder W.W., et al. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients. J Clin Endocrinol Metab. 2013; 98(10): 4143–51. DOI: 10.1210/jc.2013-1800
12. Daglar H.K., Kirbas A., Biberoglu E., Laleli B., Danisman N. Management of a multiple endocrine neoplasia type 1 during pregnancy: A case report and review of the literature. J Exp Ther Oncol. 2016; 11(3): 217–20.PMID: 28471129
13. Mistry M., Gupta M., Kaler M. Pregnancy in multiple endocrine neoplasia type 1 equals multiple complications. Obstet Med. 2014; 7(3):123–5. DOI: 10.1177/1753495X14532634
14. Thompson M., Burgess J. No evidence of adverse fertility and pregnancy outcomes in patients with unrecognized and untreated multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2019; 90(2): 312–9. DOI: 10.1111/cen.13890
15. Malekar-Raikar S., Sinnott B.P. Primary hyperparathyroidism in pregnancy-a rare cause of life-threatening hypercalcemia: case report and literature review. Case Rep Endocrinol. 2011; 2011: 520516. DOI: 10.1155/2011/520516
16. Levy S., Fayez I., Taguchi N., Han J.-Y., Aiello J., Matsui D., et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009; 44(3): 428–30. DOI: 10.1155/2011/520516
17. Vera L., Oddo S., Di Iorgi N., Bentivoglio G., Giusti M. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. J Med Case Reports. 2016; 10(1): 361. DOI: 10.1186/s13256-016-1093-2
18. Horjus C., Groot I., Telting D., van Setten P., van Sorge A., Kovacs C.S., et al. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab. 2009; 22(8):741–9.
19. Nadarasa K., Bailey M., Chahal H., Raja O., Bhat R., Gayle C., et al. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014:140056. DOI: 10.1530/EDM-14-0056
20. Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., Рожинская Л.Я., Кузнецов Н.С., Пигарова Е.А., Еремкина А.К., Егшатян Л.В., Мамедова Е.О., Крупинова Ю.А. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы леченияПроблемы эндокринологии. 2016; 62 (6): 40–77.
21. Мельниченко Г.А., Дзеранова Л.К., Пигарова Е.А., Воротникова С.Ю., Рожинская Л.Я., Дедов И.И. Федеральные клинические рекомендации по гиперпролактинемии: клиника, диагностика, дифференциальная диагностика и методы лечения. Проблемы эндокринологии. 2013; 59 (6):19–26.
22. Дедов И.И., Молитвослова Н.Н., Рожинская Л.Я., Мельниченко Г.А. Федеральные клинические рекомендации по клинике, диагностике, дифференциальной диагностике и методам лечения акромегалии. 2013; 59(6): 4–18.
23. Laway B.A. Pregnancy in acromegaly. Ther Adv Endocrinol Metab. 2015; 6(6): 267–72. DOI: 10.1177/2042018815603927
24. Lima A.D., Alves V.R., Rocha A.R., Martinhago A.C., Martinhago C., Donadio N, et al. Preimplantation genetic diagnosis for a patient with multiple endocrine neoplasia type 1: case report. JBRA Assist Reprod. 2018.; 22(1): 67–70. DOI: 10.5935/1518-0557.20180010

Поступила 04.06.2019

Принята в печать 21.06.2019